BVS Q1 2021 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

Q1 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$82M+4.0% YoY

Gross Profit

$60M72.8% margin

Operating Income

$22M26.9% margin

Net Income

$25M30.5% margin

EPS (Diluted)

$0.60

QoQ Revenue Growth

-17.1%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$19M

Stock-Based Comp.

-$22M

Balance Sheet

Total Assets

$643M

Total Liabilities

$423M

Stockholders' Equity

$142M

Cash & Equivalents

$124M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$82M	$79M	+4.0%
Gross Profit	$60M	$57M	+4.1%
Operating Income	$22M	$13M	+69.4%
Net Income	$25M	$11M	+127.9%

Revenue Segments

Pain Treatments And Joint Preservation

$42M51%

Restorative Therapies

$22M27%

Bone Graft Substitutes

$18M23%

Geographic Segments

UNITED STATES

$75M91%

Non-US

$7M9%